Table 3.
Systemic treatments of pruritus
| MEDICATION | DOSE | NOTES |
|---|---|---|
| Antihistamines | Variable depending on medication | No direct effect on pruritus except in urticaria, sedating antihistamines may be useful through their soporific effects |
|
| ||
| Antidepressants | ||
| SNRIs | Mirtazapine 7.5 - 15 mg PO qhs | Useful in nocturnal pruritus, may cause increased weight and appetite |
| SSRIs | Paroxetine 10 mg - 40 mg PO qd | Consider in psychiatric patients with pruritus and paraneoplastic pruritus |
| Fluvoxamine 25 -150 mg PO qd | Consider in psychiatric patients with pruritus and paraneoplastic pruritus |
|
| Sertraline 75 -100 mg PO qd | Useful in cholestatic pruritus | |
|
| ||
| μ-opioid receptor antagonists |
Naltrexone 25 – 50 mg PO qd | Useful in patients with cholestatic and CKD-associated pruritus, may cause nausea, vomiting and drowsiness |
|
| ||
| κ-opioid receptor agonists |
Butorphanol 1 – 4 mg intranasally qd | Useful in nocturnal and intractable pruritus, may cause nausea and vomiting as well as drowsiness |
| Nalfurafine 2.5 - 5 μg PO qd | Useful in CKD-associated pruritus, may cause insomnia, approved in Japan only |
|
|
| ||
| Neuroleptics | Gabapentin 100 – 3600 mg PO qd | Useful in neuropathic pruritus, may cause drowsiness and weight gain |
| Pregablin 150 – 300 mg PO qd | ||
| Substance P antagonist |
Aprepitant 80 mg PO qd | Benefical in pruritus associated with the Sézary syndrome, expensive |
|
| ||
| Immunosuppressants | Cyclosporin 2.5 – 5 mg/kg PO qd | Consider in atopic dermatitis patients with treatment refractory pruritus, monitor blood pressure and renal function, short term use |
| Azathioprine 2.5 mg/kg PO qd | Consider in atopic dermatitis patients with treatment refractory pruritus, monitor for myelosuppression |
|